Paratek Pharmaceuticals Inc (PRTK):企業の財務・戦略的SWOT分析

◆英語タイトル:Paratek Pharmaceuticals Inc (PRTK) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH37976FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥35,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥52,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Paratek Pharmaceuticals Inc (PRTK) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Paratek Pharmaceuticals Inc (Paratek) develops and commercializes therapies based on tetracycline chemistry. Nuzyra (Omadacycline), the company’s lead product candidate is an USFDA approved broad spectrum antibiotic for the treatment of adults with community acquired bacterial pneumonia, acute bacterial skin and skin structure infections caused by susceptible bacteria. Its other product Seysara (sarecycline) is also an USFDA approved drug for the treatment of inflammatory acne vulgaris in patients with aged nine or older. Omadacycline is also being evaluated for the treatment of female patients with uncomplicated urinary tract infection and acute pyelonephritis. Paratek is headquartered in Boston, Massachusetts, the US.

Paratek Pharmaceuticals Inc Key Recent Developments

Nov 05,2020: Paratek Pharmaceuticals announces third quarter 2020 total revenue of $13.7 million
Aug 10,2020: Paratek Pharmaceuticals announces second quarter 2020 total revenue of $9.3 million including NUZYRA (omadacycline) net revenue of $8.1 Million
May 11,2020: Paratek Pharmaceuticals announces first quarter 2020 total revenues of $7.9 million including NUZYRA (omadacycline) net sales of $7.3 million
May 11,2020: Paratek Pharmaceuticals announces first quarter 2020 total revenues of $7.9 million including NUZYRA (omadacycline) net sales of $7.3 million
Nov 12,2019: Paratek Pharmaceuticals generates net revenues of $3.9 million in the third quarter of 2019

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Paratek Pharmaceuticals Inc – Key Facts
Paratek Pharmaceuticals Inc – Key Employees
Paratek Pharmaceuticals Inc – Key Employee Biographies
Paratek Pharmaceuticals Inc – Major Products and Services
Paratek Pharmaceuticals Inc – History
Paratek Pharmaceuticals Inc – Company Statement
Paratek Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Paratek Pharmaceuticals Inc – Business Description
Paratek Pharmaceuticals Inc – Corporate Strategy
Paratek Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Paratek Pharmaceuticals Inc – Strengths
Paratek Pharmaceuticals Inc – Weaknesses
Paratek Pharmaceuticals Inc – Opportunities
Paratek Pharmaceuticals Inc – Threats
Paratek Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Paratek Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Paratek Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Paratek Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 05, 2020: Paratek Pharmaceuticals announces third quarter 2020 total revenue of $13.7 million
Aug 10, 2020: Paratek Pharmaceuticals announces second quarter 2020 total revenue of $9.3 million including NUZYRA (omadacycline) net revenue of $8.1 Million
May 11, 2020: Paratek Pharmaceuticals announces first quarter 2020 total revenues of $7.9 million including NUZYRA (omadacycline) net sales of $7.3 million
May 11, 2020: Paratek Pharmaceuticals announces first quarter 2020 total revenues of $7.9 million including NUZYRA (omadacycline) net sales of $7.3 million
Nov 12, 2019: Paratek Pharmaceuticals generates net revenues of $3.9 million in the third quarter of 2019
Sep 09, 2019: Paratek mourns passing of co-founder Dr. Stuart Levy
Aug 06, 2019: Paratek Pharmaceuticals generates net revenues of $2.0 Million in the second quarter of 2019
Jun 25, 2019: Paratek Pharmaceuticals promotes Evan Loh, M.D. to Chief Executive Officer; Michael Bigham to Assume Role of Executive Chairman
Mar 18, 2019: Paratek Pharmaceuticals announces management change
Feb 27, 2019: Paratek Pharmaceuticals reports fourth quarter and full year 2018 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Paratek Pharmaceuticals Inc, Key Facts
Paratek Pharmaceuticals Inc, Key Employees
Paratek Pharmaceuticals Inc, Key Employee Biographies
Paratek Pharmaceuticals Inc, Major Products and Services
Paratek Pharmaceuticals Inc, History
Paratek Pharmaceuticals Inc, Other Locations
Paratek Pharmaceuticals Inc, Subsidiaries
Paratek Pharmaceuticals Inc, Key Competitors
Paratek Pharmaceuticals Inc, Ratios based on current share price
Paratek Pharmaceuticals Inc, Annual Ratios
Paratek Pharmaceuticals Inc, Annual Ratios (Cont...1)
Paratek Pharmaceuticals Inc, Interim Ratios
Paratek Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Paratek Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Paratek Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Paratek Pharmaceuticals Inc (PRTK):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nishat Mills Ltd:企業の戦略・SWOT・財務分析
    Nishat Mills Ltd - Strategy, SWOT and Corporate Finance Report Summary Nishat Mills Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • SunTech Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary SunTech Medical Inc (SunTech) is a medical device company that manufactures and markets clinical-grade non-invasive blood pressure monitoring products and technologies. The company provides products such as ambulatory blood pressure monitoring products, blood pressure w and vitals, blood pre …
  • Marco’s Franchising, LLC:企業の戦略・SWOT・財務情報
    Marco's Franchising, LLC - Strategy, SWOT and Corporate Finance Report Summary Marco's Franchising, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Catabasis Pharmaceuticals Inc (CATB):製薬・医療:M&Aディール及び事業提携情報
    Summary Catabasis Pharmaceuticals Inc (Catabasis Pharmaceuticals) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes medicines for the treatment of multiple diseases. The company develops its product candidates using its proprietary safely metabolized and ratio …
  • Molecular Partners AG (MOLN):製薬・医療:M&Aディール及び事業提携情報
    Summary Molecular Partners AG (Molecular Partners) is a clinical stage biopharmaceutical company that provides biological drugs. The company provides advanced pipeline products such as abicipar, a designed ankyrin repeat protein based anti-angiogenic drug developed for diabetic macular edema and wet …
  • Seikagaku Corp (4548):製薬・医療:M&Aディール及び事業提携情報
    Summary Seikagaku Corp (Seikagaku) is a manufacturer and supplier of pharmaceuticals and medical devices. The company offers products such as pharmaceuticals and medical devices, bulk products, endotoxin-detecting reagents and oral care products. It manufactures and markets pharmaceutical products c …
  • Pharmaceutics International Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmaceutics International Inc (PII) is a contract development and manufacturing organization that offers pharmaceutical product development solutions. The organization offers manufacturing of solid, semi-solid, liquid, inhalation, parenteral and aseptic filling drugs. Its services comprise …
  • Kansas City Power & Light Co:企業の発電所・SWOT分析2018
    Kansas City Power & Light Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Newell Brands Inc (NWL):企業の財務・戦略的SWOT分析
    Newell Brands Inc (NWL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Westell Technologies Inc (WSTL):企業の財務・戦略的SWOT分析
    Summary Westell Technologies Inc (Westell) is a communication service company that provides wireless infrastructure solutions. The company offers in-building wireless, intelligent site management and communication network solutions. The company’sin-building wireless include antennas, distributed ant …
  • Banco General SA:企業の戦略・SWOT・財務情報
    Banco General SA - Strategy, SWOT and Corporate Finance Report Summary Banco General SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Ceska pojistovna a.s.:企業の戦略的SWOT分析
    Ceska pojistovna a.s. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • First Busey Corp:企業の戦略・SWOT・財務分析
    First Busey Corp - Strategy, SWOT and Corporate Finance Report Summary First Busey Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • PowerStream Inc.-エネルギー分野:企業M&A・提携分析
    Summary PowerStream Inc. (PowerStream), a subsidiary of PowerStream Holdings, Inc., is a municipality-owned energy company that provides power and related services north of Toronto and in Central Ontario. The company is jointly owned by the municipality of Markham, municipality of Vaughan, and munic …
  • Allergan Plc (AGN)-製薬・医療分野:企業M&A・提携分析
    Summary Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical aesthetics, dermatology, central nervous system, gastroenterology …
  • Cardinal Ethanol LLC (CRDE):企業の戦略的SWOT分析
    Cardinal Ethanol LLC (CRDE) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Abzena Plc (ABZA):製薬・医療:M&Aディール及び事業提携情報
    Summary Abzena Plc (Abzena), formerly Polytherics Group Ltd, is a life science company that provides complementary services and technologies to enable the selection, development and manufacture of biopharmaceuticals products based on antibodies and other proteins. The company's technologies include …
  • PT Hexindo Adiperkasa Tbk:企業の戦略・SWOT・財務情報
    PT Hexindo Adiperkasa Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Hexindo Adiperkasa Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Laurus Labs Ltd (LAURUSLABS):製薬・医療:M&Aディール及び事業提携情報
    Summary Laurus Labs Ltd (Laurus Labs) is a drug development company that manufactures active pharmaceutical ingredients. The company develops products through its business divisions such as laurus generics, ingredients and synthesis. It offers active pharmaceutical ingredients and intermediates for …
  • Wien Energie GmbH:企業の戦略的SWOT分析
    Wien Energie GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆